News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
321,013 Results
Type
Article (18024)
Company Profile (302)
Press Release (302679)
Multimedia
Podcasts (82)
Webinars (12)
Section
Business (94306)
Career Advice (485)
Deals (15589)
Drug Delivery (42)
Drug Development (52835)
Employer Resources (53)
FDA (6751)
Job Trends (6057)
News (164693)
Policy (11563)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (1093)
Accelerated approval (21)
Adcomms (14)
Allergies (90)
Alliances (23923)
ALS (128)
Alzheimer's disease (1103)
Antibody-drug conjugate (ADC) (251)
Approvals (6946)
Artificial intelligence (300)
Autoimmune disease (113)
Automation (15)
Bankruptcy (112)
Best Places to Work (5263)
BIOSECURE Act (9)
Biosimilars (121)
Biotechnology (233)
Bladder cancer (108)
Brain cancer (47)
Breast cancer (353)
Cancer (3266)
Cardiovascular disease (258)
Career advice (416)
Career pathing (17)
CAR-T (220)
CDC (6)
Cell therapy (587)
Cervical cancer (15)
Clinical research (45464)
Collaboration (1227)
Company closure (2)
Compensation (597)
Complete response letters (40)
COVID-19 (1218)
CRISPR (86)
C-suite (572)
Cystic fibrosis (115)
Data (4472)
Denatured (17)
Depression (99)
Diabetes (278)
Diagnostics (1964)
Digital health (15)
Diversity (7)
Diversity, equity & inclusion (16)
Drug discovery (194)
Drug pricing (56)
Drug shortages (6)
Duchenne muscular dystrophy (214)
Earnings (42283)
Editorial (28)
Employer branding (8)
Employer resources (46)
Events (54438)
Executive appointments (652)
FDA (8712)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (1014)
Gene editing (183)
Generative AI (26)
Gene therapy (509)
GLP-1 (575)
Government (1367)
Grass and pollen (5)
Guidances (282)
Healthcare (7758)
HIV (21)
Huntington's disease (44)
IgA nephropathy (78)
Immunology and inflammation (201)
Immuno-oncology (40)
Indications (70)
Infectious disease (1333)
Inflammatory bowel disease (156)
Inflation Reduction Act (10)
Influenza (46)
Intellectual property (169)
Interviews (84)
IPO (8571)
IRA (17)
Job creations (1065)
Job search strategy (356)
JPM (47)
Kidney cancer (9)
Labor market (33)
Layoffs (282)
Leadership (17)
Legal (1735)
Liver cancer (44)
Longevity (12)
Lung cancer (440)
Lymphoma (262)
Machine learning (30)
Management (14)
Manufacturing (418)
MASH (132)
Medical device (3934)
Medtech (3951)
Mergers & acquisitions (7692)
Metabolic disorders (801)
Multiple sclerosis (113)
NASH (13)
Neurodegenerative disease (237)
Neuropsychiatric disorders (72)
Neuroscience (2063)
Neurotech (1)
NextGen: Class of 2026 (2564)
Non-profit (1152)
Now hiring (34)
Obesity (375)
Opinion (171)
Ovarian cancer (133)
Pain (110)
Pancreatic cancer (166)
Parkinson's disease (236)
Partnered (16)
Patents (315)
Patient recruitment (333)
Peanut (48)
People (28509)
Pharmaceutical (44)
Pharmacy benefit managers (11)
Phase 1 (15846)
Phase 2 (20991)
Phase 3 (13584)
Pipeline (3621)
Policy (108)
Postmarket research (1002)
Preclinical (6673)
Press Release (30)
Prostate cancer (158)
Psychedelics (52)
Radiopharmaceuticals (240)
Rare diseases (667)
Real estate (1652)
Recruiting (20)
Regulatory (11005)
Reports (25)
Research institute (1100)
Resumes & cover letters (66)
Rett syndrome (26)
RNA editing (21)
RSV (19)
Schizophrenia (126)
Series A (184)
Series B (141)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (126)
Sponsored (22)
Startups (2130)
State (1)
Stomach cancer (7)
Supply chain (41)
Tariffs (23)
The Weekly (64)
Vaccines (367)
Venture capital (73)
Weight loss (214)
Women's health (34)
Worklife (5)
Date
Last 7 days (367)
Last 30 days (1187)
Last 365 days (19294)
2026 (1747)
2025 (19647)
2024 (22300)
2023 (24522)
2022 (30880)
2021 (31675)
2020 (26943)
2019 (19419)
2018 (14190)
2017 (15510)
2016 (13434)
2015 (16225)
2014 (11763)
2013 (8469)
2012 (8777)
2011 (8915)
2010 (8611)
Location
Africa (251)
Alabama (66)
Alaska (3)
Arizona (81)
Arkansas (5)
Asia (20272)
Australia (3548)
California (7472)
Canada (2004)
China (812)
Colorado (275)
Connecticut (276)
Delaware (240)
Europe (44179)
Florida (1024)
Georgia (220)
Hawaii (3)
Idaho (23)
Illinois (443)
India (36)
Indiana (205)
Iowa (9)
Japan (238)
Kansas (80)
Kentucky (13)
Louisiana (15)
Maine (18)
Maryland (795)
Massachusetts (5824)
Michigan (140)
Minnesota (281)
Mississippi (3)
Missouri (39)
Montana (22)
Nebraska (10)
Nevada (37)
New Hampshire (32)
New Jersey (1816)
New Mexico (15)
New York (1922)
North Carolina (913)
North Dakota (6)
Northern California (3678)
Ohio (190)
Oklahoma (11)
Oregon (24)
Pennsylvania (1404)
Puerto Rico (10)
Rhode Island (25)
South America (336)
South Carolina (13)
South Dakota (1)
Southern California (2947)
Tennessee (58)
Texas (991)
United States (25183)
Utah (126)
Virginia (154)
Washington D.C. (39)
Washington State (631)
West Virginia (1)
Wisconsin (55)
321,013 Results for "gain therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Gain Therapeutics Highlights Biomarker Evidence Supporting Disease-Modifying Potential of GT-02287
January 6, 2026
·
7 min read
Press Releases
Gain Therapeutics to Present at Neuroscience 2025
October 31, 2025
·
5 min read
Press Releases
Gain Therapeutics Announces Announces Conference Participation During J.P. Morgan Healthcare Conference Week
January 7, 2026
·
5 min read
Press Releases
Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2025
November 21, 2025
·
8 min read
Press Releases
Gain Therapeutics to Attend the 2025 Maxim Growth Summit
October 17, 2025
·
4 min read
Press Releases
Gain Therapeutics Reports Financial Results for Third Quarter 2025 and Provides Corporate Update
November 13, 2025
·
14 min read
Press Releases
Biocomposites gains MDR certification for STIMULAN® Rapid Cure and STIMULAN® Kit
February 5, 2026
·
2 min read
Press Releases
Gain Therapeutics to Participate at Drug Discovery Innovation Programme 2025
September 24, 2025
·
4 min read
Press Releases
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
October 9, 2025
·
8 min read
Press Releases
Gain Therapeutics Announces Positive Results in Key Exploratory Endpoint from its Phase 1b Clinical Study of GT-02287 in People with Parkinson’s Disease
December 18, 2025
·
8 min read
1 of 32,102
Next
